Maternal Health Notice of Intent to Announce - POCTRN
null Maternal Health Notice of Intent to Announce
Coming Soon: NIH RADx® Tech for Maternal Health Challenge
The National Institutes of Health will announce the Rapid Acceleration of Diagnostics Technology (RADx® Tech) for Maternal Health Challenge as part of the Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE) Initiative, which supports research to reduce preventable causes of maternal deaths and to improve health for women before, during and after delivery.
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), and the NIH Office of the Director are co-sponsoring this challenge, which is offering up to $8 million in cash prizes to accelerate development of technologies to improve maternal health outcomes for those who live in areas lacking access to maternity care. The challenge will prioritize home-based or point-of-care diagnostic devices, wearables, and other remote sensing technologies to extend care and improve health outcomes during the postpartum period.
The challenge will launch on September 15, 2022. Submissions for the multi-phase competition are due November 1, 2022, and final winners are expected to be announced in March 2024. For more information
RADx: Rapid Acceleration of Diagnostics
In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADxsm) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.